Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma
Clinical trial NCT07354282 · COMPLETED
Trial details
- NCT number
- NCT07354282
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-13
- Primary completion
- 2025-08-07
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.